Skip to Content
Skip to Content

Cheminės medžiagos vertinimas. Koreguojamasis Bendrijos veiksmų planas (CoRAP)

Cheminės medžiagos vertinimas. Koreguojamasis Bendrijos veiksmų planas (CoRAP)

For each substance, the table shows the evaluating Member State, the year of evaluation and a short description of the concern which led to it being placed on the list.

Community rolling action plan (CoRAP): The community rolling action plan covers three consecutive years and is updated mid of March every year. From this it follows that substances in the table below with the column ‘Year’ indicating a current or future year, are those that have been prioritised for evaluation, and are effectively on the current CoRAP.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation and CoRAP table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

  • Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
  • CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
  • Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
  • Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
  • Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
  • RCR: Risk Characterisation Ratio
Last updated 13 gruodis 2019. Database contains 375 unique substances/entries.
Filter the list
Initial grounds for concern:

 
236-675-5
13463-67-7
2018
France
Carcinogenic
Suspected Mutagenic
Other hazard based concern
Ongoing
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Conclusion under preparation
Details
310-154-3
121158-58-5
2018
Germany
Potential endocrine disruptor
Concluded
Details
214-263-6
1118-46-3
2018
France
Suspected Mutagenic
Suspected Reprotoxic
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Suspended
Details
203-475-4
107-25-5
2018
Latvia
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Exposure of workers
Other exposure/risk based concern
Concluded
Details
203-584-7
108-45-2
2018
Latvia
Suspected Reprotoxic
Sensitiser
Exposure of workers
High (aggregated) tonnage
Concluded
Details
202-510-0
96-49-1
2018
Latvia
Suspected Reprotoxic
Other hazard based concern
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
215-175-0
1309-64-4
2018
Germany
Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
201-159-0
78-93-3
2018
Sweden
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
700-183-3
52299-25-9
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Concluded
Details
233-047-2
10025-91-9
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Concluded
Details
215-713-4
1345-04-6
2018
Germany
Suspected Carcinogenic
Exposure of workers
High RCR
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
231-146-5
7440-36-0
2018
Germany
Suspected Carcinogenic
Exposure of workers
High (aggregated) tonnage
High RCR
Other exposure/risk based concern
Wide dispersive use
Ongoing
Details
-
-
2018
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
202-653-9
98-29-3
2018
Poland
Suspected Mutagenic
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Exposure of environment
Exposure of workers
Concluded
Details
215-925-7
1453-58-3
2018
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Ongoing
Details
435-790-1
297730-93-9
2018
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
266-733-5
67584-55-8
2018
Germany
Suspected PBT/vPvB
Other hazard based concern
Exposure of environment
Wide dispersive use
Concluded
Details
249-820-2
29736-75-2
2018
Germany
Suspected Carcinogenic
Suspected Reprotoxic
Other hazard based concern
Exposure of workers
Ongoing
Details
262-872-0
61617-00-3
2018
Germany
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
258-904-8
53988-10-6
2018
Germany
Potential endocrine disruptor
Exposure of environment
Ongoing
Details
215-222-5
1314-13-2
2017
Germany
Other hazard based concern
Consumer use
Exposure of environment
Other exposure/risk based concern
Wide dispersive use
Information requested
Details
204-112-2
115-86-6
2017
France
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Information requested
Details
700-579-6
-
2017
Netherlands
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
430-050-2
-
2017
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
915-730-3
-
2017
France
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Ongoing
Details
264-120-7
63393-96-4
2017
Italy
Suspected PBT/vPvB
Exposure of environment
High RCR
Wide dispersive use
Information requested
Details
432-240-0
12056-51-8
2017
France
Carcinogenic
Exposure of workers
Information requested
Details
231-760-3
7722-64-7
2017
France
Suspected Reprotoxic
Consumer use
Exposure of sensitive populations
Concluded
Details
444-340-1
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
-
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
251-118-6
32588-76-4
2017
Norway
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
215-575-5
1332-77-0
2017
Lithuania
Reprotoxic
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
DCHP
201-545-9
84-61-7
2017
Sweden
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Information requested
Details
200-751-6
71-36-3
2017
Hungary
Suspected Reprotoxic
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
700-323-3
908020-52-0
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
700-242-3
62037-80-3
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Information requested
Details
480-310-4
-
2017
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Ongoing
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
203-614-9
108-77-0
2017
Poland
Suspected Reprotoxic
Suspected PBT/vPvB
Exposure of environment
High (aggregated) tonnage
Concluded
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
244-617-5
21850-44-2
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Ongoing
Details
306-832-3
97416-84-7
2017
Germany
Potential endocrine disruptor
Suspected PBT/vPvB
Exposure of environment
Ongoing
Details
231-302-2
7488-55-3
2016
France
Suspected CMR
Sensitiser
Consumer use
High (aggregated) tonnage
Information requested
Details
231-890-0
7775-14-6
2016
Austria
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
203-585-2
108-46-3
2016
Finland
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details
EC No. 415-490-5 and 604-250-7
-
-
2016
Germany
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
272-486-4
68855-45-8
2016
France
CMR
Suspected PBT/vPvB
Consumer use
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
271-867-2
68610-51-5
2016
Spain
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Information requested
Details

Export search results to:

Categories Display

Pažymėta kaip:

(spustelėkite žymę norėdami ieškoti atitinkamo turinio)


Route: .live1